Viewing Study NCT06763302


Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2026-02-23 @ 1:10 AM
Study NCT ID: NCT06763302
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-01-08
First Post: 2024-12-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALL
Sponsor: The Children's Hospital of Zhejiang University School of Medicine
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B Cell Precursor Acute Lymphoblastic Leukemia View
None Pediatric View
None Minimal Residual Disease View
None Next Generation Sequencing (NGS) View
Keywords: